Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marianne Davies

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Seminars in Oncology Nursing|September 14, 2019
Acute and Long-term Adverse Events Associated With Checkpoint BlockadeMarianne Davies
Cancer Management and Research|February 13, 2014
New modalities of cancer treatment for NSCLC: focus on immunotherapyMarianne Davies
Journal of the Advanced Practitioner in Oncology|December 29, 2017
How Checkpoint Inhibitors Are Changing the Treatment Paradigm in Solid Tumors: What Advanced Practitioners in Oncology Need to KnowMarianne Davies
Clinical Journal of Oncology Nursing|May 23, 2022
Oncogenic-Directed Therapy for Advanced Non-Small Cell Lung Cancer: Implications for the Advanced Practice NurseMarianne Davies
AANA Journal|July 29, 2020
Evidence-Based Antiemetic Decision Tool for Management of Postoperative Nausea and Vomiting in Patients at High Risk of QT Prolongation and Patients Receiving Neurotransmitter-Modulating MedicationsNicole Hymel, Marianne Davies
Clinical Journal of Oncology Nursing|May 23, 2020
Durvalumab Immunotherapy: Nursing Management of Immune-Related Adverse Events During the Journey of Patients With Stage III Non-Small Cell Lung CancerMarianne Davies, Emily Duffield
Journal of the National Comprehensive Cancer Network : JNCCN|May 23, 2019
NCCN Guidelines Updates: New Immunotherapy Strategies for Improving Outcomes in Non-Small Cell Lung CancerMatthew A Gubens, Marianne Davies
Immunotargets and Therapy|September 13, 2017
Safety of checkpoint inhibitors for cancer treatment: strategies for patient monitoring and management of immune-mediated adverse eventsMarianne Davies, Emily A Duffield
Frontiers in Sports and Active Living|June 9, 2023
Every story has two sides: evaluating information processing and ecological dynamics perspectives of focus of attention in skill acquisitionVictoria Gottwald, Marianne Davies, Robin Owen
Cancer Treatment Reviews|February 21, 2020
Toxicity management with combination chemotherapy and programmed death 1/programmed death ligand 1 inhibitor therapy in advanced lung cancerBrianna Hoffner, Natasha B Leighl, Marianne Davies
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Seminars in Oncology Nursing|September 14, 2019
Acute and Long-term Adverse Events Associated With Checkpoint BlockadeMarianne Davies
Cancer Management and Research|February 13, 2014
New modalities of cancer treatment for NSCLC: focus on immunotherapyMarianne Davies
Journal of the Advanced Practitioner in Oncology|December 29, 2017
How Checkpoint Inhibitors Are Changing the Treatment Paradigm in Solid Tumors: What Advanced Practitioners in Oncology Need to KnowMarianne Davies
Clinical Journal of Oncology Nursing|May 23, 2022
Oncogenic-Directed Therapy for Advanced Non-Small Cell Lung Cancer: Implications for the Advanced Practice NurseMarianne Davies
AANA Journal|July 29, 2020
Evidence-Based Antiemetic Decision Tool for Management of Postoperative Nausea and Vomiting in Patients at High Risk of QT Prolongation and Patients Receiving Neurotransmitter-Modulating MedicationsNicole Hymel, Marianne Davies
Clinical Journal of Oncology Nursing|May 23, 2020
Durvalumab Immunotherapy: Nursing Management of Immune-Related Adverse Events During the Journey of Patients With Stage III Non-Small Cell Lung CancerMarianne Davies, Emily Duffield
Journal of the National Comprehensive Cancer Network : JNCCN|May 23, 2019
NCCN Guidelines Updates: New Immunotherapy Strategies for Improving Outcomes in Non-Small Cell Lung CancerMatthew A Gubens, Marianne Davies
Immunotargets and Therapy|September 13, 2017
Safety of checkpoint inhibitors for cancer treatment: strategies for patient monitoring and management of immune-mediated adverse eventsMarianne Davies, Emily A Duffield
Frontiers in Sports and Active Living|June 9, 2023
Every story has two sides: evaluating information processing and ecological dynamics perspectives of focus of attention in skill acquisitionVictoria Gottwald, Marianne Davies, Robin Owen
Cancer Treatment Reviews|February 21, 2020
Toxicity management with combination chemotherapy and programmed death 1/programmed death ligand 1 inhibitor therapy in advanced lung cancerBrianna Hoffner, Natasha B Leighl, Marianne Davies
Pageof 3